Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-10

FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Tizanidine Hydrochloride from Aurobindo Pharma Limited under an ANDA. This action confirms regulatory clearance for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tizanidine hydrochloride (Tizanidine hydrochloride)

Snippet

SUPPL AP for TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE)